Manuka, Inc.

MNKA

US04302Q1094

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 12:45:10 2024-05-09 pm EDT			5-day change	1st Jan Change
0.03 ^USD	-25.00%		0.00%	-58.33%

2023	Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

New York Global Innovations, Inc. will Change its Name to Artemis Therapeutics, Inc

December 20, 2016 at 12:00 am EST

Effective December 20, 2016, New York Global Innovations, Inc. will change its name to Artemis Therapeutics, Inc.

Latest news about Manuka, Inc.

Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 21	CI
Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
Manuka, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-18	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
Artemis Therapeutics Inc. Announces Executive Changes	22-07-26	CI
Manuka Ltd completed the acquisition of Artemis Therapeutics Inc. in a reverse merger transaction.	22-06-29	CI
Artemis Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Manuka Ltd entered into a share exchange agreement to acquire Artemis Therapeutics Inc. for $92.4 million in a reverse merger transaction.	22-03-08	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-03	CI
Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt	22-03-02	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Artemis Therapeutics Inc. Issues Two Unsecured Promissory Notes	21-11-08	CI
Artemis Therapeutics Inc. announced that it has received $0.06 million in funding from KNRY, Ltd., Harmony (H.A.) Investments Ltd.	21-11-03	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-23	CI
Vale S A : , BHP propose 1.2 bln reais DIP financing for Samarco, creditors oppose	21-06-15	RE
Artemis Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt	21-03-29	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-09	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Artemis Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-14	CI
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI

Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Companyâs products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
MANUKA, INC.	-58.33%	3.36M
VERTEX PHARMACEUTICALS INCORPORATED	+9.83%	118B
REGENERON PHARMACEUTICALS, INC.	+10.80%	106B
BIONTECH SE	-10.84%	23.4B
ARGENX SE	-1.69%	22.1B
GENMAB A/S	-10.23%	18.34B
WUXI APPTEC CO., LTD.	-41.92%	16.59B
BEIGENE, LTD.	-15.11%	15.97B
NEUROCRINE BIOSCIENCES, INC.	+6.62%	14.03B
SAREPTA THERAPEUTICS, INC.	+17.53%	11.67B